Generation Investment Management LLP reduced its holdings in 10x Genomics, Inc. (NASDAQ:TXG – Get Rating) by 2.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,548,100 shares of the company’s stock after selling 57,577 shares during the quarter. Generation Investment Management LLP […]
10x Genomics, Inc. (NASDAQ:TXG – Get Rating) Director Mathai Mammen sold 33,000 shares of the company’s stock in a transaction on Thursday, May 11th. The shares were sold at an average price of $52.82, for a total transaction of $1,743,060.00. Following the completion of the transaction, the director now owns 169,745 shares of the company’s […]
10x Genomics, Inc. (NASDAQ:TXG – Get Rating) Director Mathai Mammen sold 33,000 shares of the stock in a transaction on Thursday, May 11th. The stock was sold at an average price of $52.82, for a total value of $1,743,060.00. Following the transaction, the director now owns 169,745 shares of the company’s stock, valued at $8,965,930.90. […]
Abundance Wealth Counselors bought a new position in 10x Genomics, Inc. (NASDAQ:TXG – Get Rating) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 6,443 shares of the company’s stock, valued at approximately $235,000. Several other hedge funds have also modified their […]
Barclays initiated coverage on shares of 10x Genomics (NASDAQ:TXG – Get Rating) in a research report issued to clients and investors on Wednesday, The Fly reports. The brokerage set an “overweight” rating and a $65.00 price target on the stock. Barclays‘s price target indicates a potential upside of 23.50% from the stock’s previous close. TXG […]